Summary
The properties of MDL 72222 (1αH,3α,5αH-tropan-3-yl-3,5-dichlorobenzoate), a novel compound with potent and selective blocking actions at certain excitatory 5-hydroxytryptamine (5-HT) receptors on mammalian peripheral neurones, are described.
On the rabbit isolated heart, MDL 72222 was a potent antagonist of responses mediated through the receptors for 5-HT present on the terminal sympathetic fibres. The threshold for antagonism was approximately 0.1 nM and the negative logarithm of the molar concentration of MDL 72222 which reduced the chronotropic response of the isolated rabbit heart to twice an ED50 of 5-HT to that of the ED50 was 9.27. MDL 72222 was also highly selective since responses to the nicotine receptor agonist, dimethylphenylpiperazinum iodine (DMPP), were inhibited only at concentrations more than 1000 times those necessary to inhibit 5-HT.
In the anaesthetised rat, MDL 72222 produced marked blockade of the Bezold-Jarisch effect of 5-HT. Again, inhibition was selective since much higher doses of MDL 72222 failed to alter the response to electrical stimulation of the efferent vagus nerves. In contrast, MDL 72222 proved only a weak and essentially non-selective antagonist of responses mediated by the 5-HT M-receptor present on the cholinergic nerves of the guinea-pig ileum.
MDL 72222 does not block smooth muscle contractile responses elicited by oxytocin or mediated through 5-HT D-receptors, muscarinic or nicotinic cholinoceptors or histamine H1-receptors except at relatively high concentrations. Similarly, in a number of radioligand binding assays carried out using brain tissue membranes, the displacing effects of MDL 72222 were absent or weak at sites identifying compounds with activity at α1, α2 or β-adrenoceptors, 5-HT1 or 5-HT2 receptors, benzodiazepine receptors or histamine H1-receptors.
MDL 72222 is the first reported selective and potent antagonist of responses mediated through the 5-HT receptors present on the terminal sympathetic neurones of the rabbit heart and on the neurones subserving the afferent limb of the Bezold-Jarisch reflex. The compound should provide a useful means by which responses mediated through such sites can be distinguished.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aghajanian GK (1981) The modulatory role of serotonin at multiple receptors in brain. In: Jacobs BL, Gelperin A (eds) Serotonin neurotransmission and behavior. The MIT Press, Cambridge, Massachussetts, pp 156–185
Bülbring E, Wajda I (1945) Biological comparison of local anaesthetics. J Pharmacol Exp Ther 85:78–84
Day MD, Vane JR (1963) An analysis of the direct and indirect actions of drugs on the isolated guinea-pig ileum. Br J Pharmacol 20:150–170
Fozard JR (1979) Blockade of receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart. In: Langer SZ, Starke K, Dubocovich ML (eds) Advances in the biosciences. Pergamon, Oxford, pp 327–332
Fozard JR (1982) Basic mechanisms of antimigraine drugs. In: Critchley M, Friedman AP, Gorini S, Sicuteri F (eds) Advances in neurology, vol 33, Headache: physiopathological and clinical concepts. Raven Press, New York, pp 295–307
Fozard JR (1983a) MDL 72222: A potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Br J Pharmacol 80:466P
Fozard JR (1983b) Differences between receptors for 5-hydroxytryptamine on autonomic neurones revealed by nor-(−)-cocaine. J Auton Pharmacol 3:21–26
Fozard JR, Gittos MW (1983) Selective blockade of 5-hydroxytryptamine neuronal receptors by benzoic acid esters of tropine. Br J Pharmacol 80:511P
Fozard JR, Host M (1982) Selective inhibition of the Bezold-Jarisch effect of 5-HT in the rat by antagonists at neuronal 5-HT receptors. Br J Pharmacol 77:520P
Fozard JR, Leach GDH (1968) The hypotensive action of 5-hydroxytryptamine (5-HT) in anaesthetized and pithed rats. Eur J Pharmacol 2:239–249
Fozard JR, Mobarok Ali ATM (1978a) Blockade of neuronal tryptamine receptors by metoclopramide. Eur J Pharmacol 49:109–112
Fozard JR, Mobarok Ali ATM (1978b) Receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 301:223–235
Fozard JR, Muscholl E (1971) A useful muscarinic parameter and the differential recording of atrial and ventricular tension in the perfused rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 270:319–325
Fozard JR, Mwaluko GMP (1976) Mechanism of the indirect sympathomimetic effect of 5-hydroxytryptamine on the isolated heart of the rabbit. Br J Pharmacol 57:115–125
Fozard JR, Mobarok Ali ATM, Newgrosh G (1979) Blockade of serotonin receptors on autonomic neurones by (−)-cocaine and some related compounds. Eur J Pharmacol 59:195–210
Gaddum JH, Picarelli ZP (1957) Two kinds of tryptamine receptor. Br J Pharmacol Chemother 12:323–328
Gerschenfeld HM, Paupardin-Tritsch D, Deterre D (1981) Neuronal responses to serotonin: A second view. In: Jacobs BL, Gelperin A (eds) Serotonin neurotransmission and behavior. The MIT Press, Cambridge, Massachussetts, pp 105–130
Giachetti A, Hammer R, Montagna E (1982) Muscarinic receptor subtypes and responses to McN A-343 and pirenzepine. Br J Pharmacol 77:428P
Göthert M, Dührsen V (1979) Effects of 5-hydroxytryptamine and related compounds on the sympathetic nerves of the rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 308:9–18
Haefely W (1972) Electrophysiology of the adrenergic neurone. In: Blaschko H, Muscholl E (ed) Handbook of experimental pharmacology, vol 23, Catecholamines. Springer, Berlin Heidelberg New York, pp 661–725
Haefely W (1974a) Muscarinic postsynaptic events in the cat superior cervical ganglion in situ. Naunyn-Schmiedeberg's Arch Pharmacol 281:119–143
Haefely W (1974b) The effects of 5-hydroxytryptamine and some related compounds on the cat superior cervical ganglion in situ. Naunyn-Schmiedeberg's Arch Pharmacol 281:145–165
Jacob J, Poite-Bevièrre M (1960) Actions de la sérotonine et de la benzyl-1-diméthyl-2,5-sérotonine sur le coeur isolé de lapin. Arch Int Pharmacodyn Ther 127:11–26
Krayer O (1961) The history of the Bezold-Jarisch effect. Naunyn-Schmiedebergs Arch Pharmacol 240:361–368
Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenbeck J, Janssen PAJ (1981) Receptor binding profile of R41468 a novel antagonist at 5-HT2 receptors. Life Sci 28:1115–1122
Paintal AS (1973) Vagal sensory receptors and their reflex effects. Physiol Rev 53:159–227
Salmoiraghi GC, Page IH, McGubbin JW (1956) Cardiovascular and respiratory response to intravenous serotonin in rats. J Pharmacol Exp Ther 118:477–481
Schild HO (1947) pA, a new scale for the measurement of drug antagonism. Br J Pharmacol 2:189–206
Shipley RE, Tilden JH (1947) A pithed rat preparation suitable for assaying presor substances. Proc Soc Exp Biol Med 64:453–455
Spedding M (1982) Assessment of “Ca2+-antagonist” effects of drugs in K+-depolarized smooth muscle: differentiation of antagonist subgroups. Naunyn-Schmiedeberg's Arch Pharmacol 318:234–240
University of Edinburgh Staff (1970) Pharmacological experiments on isolated preparations. Livingstone, Edinburgh London
Wallis DI (1979) The apparent multiplicity of ganglionic receptors. In: Kalsner (ed) Trends in autonomic pharmacology, vol 1. Urban and Schwarzenberg, Baltimore, pp 21–57
Wallis D (1981) Neuronal 5-hydroxytryptamine receptors outside the central nervous system. Life Sci 29:2345–2355
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fozard, J.R. MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 326, 36–44 (1984). https://doi.org/10.1007/BF00518776
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00518776